PRInnovation GmbH, a subsidiary of SPRIND, is working on the clinical development of a drug candidate against Alzheimer's dementia with an innovative mechanism of action. We are cooperating closely with the company Priavoid. Currently we are running the Clinical Phase 2 PRImus-AD study. The ongoing progress of the study requires additional support for our ambitious team. Therefore we are looking for an experienced
CLINICAL TRIAL MANAGER
for coordinating the sponsor´s oversight activities and drug supply on demand in clinical research
FULL TIME | INITIALLY LIMITED UNTIL DECEMBER 2026 | AS SOON AS POSSIBLE
We, PRInnovation GmbH, are a foundation of the Federal Agency for Disruptive Innovation (SPRIND). SPRIND itself was founded by the Federal Ministry of Education and Research (BMBF) and the Federal Ministry for Economic Affairs and Energy (BMWi). With the aim of creating new disruptive innovations from Germany.
We at PRInnovation, based in Leipzig and Düsseldorf, are currently working on a so-called disruptive innovation.
APCT1_DE